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Purpose: Bioprinting is becoming an increasingly popular platform technology for
engineering a variety of tissue types. Our aim was to identify biomaterials that have been
found to be suitable for extrusion 3D bioprinting, outline their biomechanical properties
and biocompatibility towards their application for bioprinting specific tissue types. This
systematic review provides an in-depth overview of current biomaterials suitable for
extrusion to aid bioink selection for specific research purposes and facilitate design of
novel tailored bioinks.
Methods: A systematic search was performed on EMBASE, PubMed, Scopus and
Web of Science databases according to the PRISMA guidelines. References of relevant
articles, between December 2006 to January 2018, on candidate bioinks used in
extrusion 3D bioprinting were reviewed by two independent investigators against
standardised inclusion and exclusion criteria. Data was extracted on bioprinter brand
and model, printing technique and specifications (speed and resolution), bioink material
and class of mechanical assessment, cell type, viability, and target tissue. Also noted
were authors, study design (in vitro/in vivo), study duration and year of publication.
Results: A total of 9,720 studies were identified, 123 of which met inclusion criteria,
consisting of a total of 58 reports using natural biomaterials, 26 using synthetic
biomaterials and 39 using a combination of biomaterials as bioinks. Alginate (n = 50)
and PCL (n = 33) were the most commonly used bioinks, followed by gelatin (n = 18)
and methacrylated gelatin (GelMA) (n = 16). Pneumatic extrusion bioprinting techniques
were the most common (n = 78), followed by piston (n = 28). The majority of studies
focus on the target tissue, most commonly bone and cartilage, and investigate only
one bioink rather than assessing a range to identify those with the most promising
printability and biocompatibility characteristics. The Bioscaffolder (GeSiM, Germany), 3D
Discovery (regenHU, Switzerland), and Bioplotter (EnvisionTEC, Germany) were the most
commonly used commercial bioprinters (n = 35 in total), but groups most often opted to
create their own in-house devices (n = 20). Many studies also failed to specify whether
the mechanical data reflected pre-, during or post-printing, pre- or post-crosslinking and
with or without cells.
Tarassoli et al. Candidate Bioinks for Extrusion Bioprinting
Conclusions: Despite the continued increase in the variety of biocompatible
synthetic materials available, there has been a shift change towards using natural
rather than synthetic bioinks for extrusion bioprinting, dominated by alginate either
alone or in combination with other biomaterials. On qualitative analysis, no link
was demonstrated between the type of bioink or extrusion technique and the
target tissue, indicating that bioprinting research is in its infancy with no established
tissue specific bioinks or bioprinting techniques. Further research is needed on side-
by-side characterisation of bioinks with standardisation of the type and timing of
biomechanical assessment.
Keywords: bioprinting, bioink, extrusion, systematic review, regenerative medicine
INTRODUCTION
Bioprinting is defined as the precise and accurate deposition
of biomaterials simultaneously with cells, within a predesigned
space using a computer-aided printer (Langer and Tirrell, 2004;
Mironov, 2005). The process was first described in 1988 (Klebe,
1988) as “cytoscribing” which involved depositing coloured
inks in three-dimensions (3D), inspired by the two-dimensional
(2D) paper printers that preceded them. Since then, biological
materials have been used and increasingly complex printing
methods developed which have made significant contributions
to this evolving field (Lee et al., 2010; Benwood et al., 2021).
These printable biomaterials, known as bioinks, can mimic
the extracellular matrix (ECM) environment to support cell
adhesion, differentiation and proliferation. Bioinks differ from
other inks used in additive manufacturing (or 3D printing) in
that theymust serve both biological andmechanical functions. As
such, they are printed at much lower temperatures, are typically
derived naturally and have mild cross-linking conditions to
preserve the cells and prevent unwanted degradation of the
biomolecules (Malda et al., 2013).
Several bioprinting technologies have been explored, from
inkjet and stereolithography to laser-assisted (3). Extrusion
based techniques, also known as fused deposition modelling or
bioplotting, are the most commonly used and involve extrusion
of a viscous material containing cells, as a continuous filament
Abbreviations: ABS, Acrylonitrile butadiene styrene; ADSC, Adipose Derived
Stem Cell; ASSMC, Aortic sinus smooth muscle cells; BMPC, Bone marrow
plasma cell; B-TCP, Beta tricalcium phosphate; CM, Compressive Modulus;
ECM, Extracellular matrix; EM (Compressive), Elastic Modulus; EPC, Endothelial
progenitor cell; HAMA, Hyaluronic Acid Methyacrylate; HAVIC, Human aortic
valve interstitial cell; HDMEC, Human Brain Microvascular Endothelial cell;
htMSC, Human turbinate mesenchymal stem cells; HUCPVC, Human Umbilical
Cord Perivascular Cells; HUVEC, Human umbilical vein endothelial cell;
MCS, Maximum Compressive Strength; MSC, Mesenchymal stem cell; P(AGE-
co-G), Ally-functionalised poly(glycidol)s; PAEC, Porcine aorta endothelial
cells; PBT, Polybutylene terephthalate; PCL, Polycaprolactone; PDLLA, Poly-
DL-lactic acid; PEG-DA, Polyethylene glycol diacrylate; PEOT, Poly(ethylene
oxide terephthalate); PEU, Poly ether urethane; PGS, Pyrolytic graphite sheet;
pHMGCL, Phenyl magnesium chloride; PLGA, Poly-lactic-co-glycolic acid; PPF,
Polypropylene fumarate; PU, Polyurethane; PUPEO, Polyurethane Polyethylene
oxide; PVA, Polyvinyl acetate; RCS, Residual Compressive Stress; SM, Shear
Storage Modulus; SEM, Shear Elastic Modulus; SVF, Stromal vascular fraction;
TPU, Thermoplastic polyurethane; V, Viscosity.
through a nozzle using either a pneumatic, piston, or screw
forces (Landers et al., 2002; Jakab et al., 2008). After printing,
the constructs can be solidified (i.e., gelled) layer-by-layer
either physically or chemically, which makes this technique
slower than others such as laser assisted or ink jet based
(Landers et al., 2002; Smith et al., 2004; Jakab et al., 2008).
However, the cost effectiveness (many are made from modifying
commercially available 3D printers), simplicity and high cell
viability makes extrusion bioprinting a popular choice for most
research institutions and is the basis of the first commercial
3D bioprinter (Organovo Novogen MMX BioprinterTM) (Jürgen
et al., 2016). The main limiting factors relate to achieving a
high enough resolution to enable reproduction of native nano-
and micro-architecture and maintaining post printing shape
fidelity to enable bioprinting of complex macrostructures. The
resolution itself will depend on the tissue type attempted to be
recreated e.g., bundles and cell alignments for muscle bioprinting
demanded a bioprinting resolution of <50µm whereas some of
the finest features of tissue microarchitectures required ∼10µm
and mainly limited by the size of the individual cells themselves
(Miri et al., 2019). These in turn depend on optimal material
rheology and crosslinking ability (Jessop et al., 2017; Kyle et al.,
2017).
The desirable characteristics of scaffolds for tissue engineering
have been well-described (Hutmacher, 2000; Hollister, 2005; Al-
Himdani et al., 2017), whereas those of bioinks are less well-
defined (Kyle et al., 2017). The development and discovery
of bioinks has had a staggered past with no natural research
evolution (Tarassoli et al., 2018b). Initial studies used existing
natural polymers (such as alginate or gelatin) for bioprinting
rather than tailoring biomechanics to suit individual bioprinters
(Boland et al., 2003; Jakab et al., 2004). These bioinks are
still commonplace in modern bioprinting laboratory practise
either alone or in combination with other biomaterials. More
recent developments include smart polymers, consisting of
synthetic materials with bioactive proteins to enable modification
of biomechanical and biocompatibility properties, respectively
(Galaev and Mattiasson, 1999). Their design allows for them
to respond to specific stimuli (such as temperature, magnetism,
ionic etc.) (Wei et al., 2017), but these are not necessarily
optimised for extrusion bioprinting. Work has been carried out
in the field of smart polymers in 3d bioprinting and cell therapy
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and is becoming an emerging avenue for further research (Huang
et al., 2019).
Bioinks are classified as natural or synthetic. Natural bioinks
differ to synthetic bioinks in their ability to mimic the native
cellular microenvironment, offering support to growing cells and
thereby increasing the likelihood of cell adhesion and secretion
of matrix. On the other hand, synthetic bioinks are easier to
tailor for efficient printability (Gopinathan and Noh, 2018).
Many features of bioinks, such as biodegradability, ability to
functionalise and sterilise, will naturally overlap with those of
conventional scaffolds used for tissue engineering applications
(Al-Himdani et al., 2017). However, the requirement for
“printability” of bioinks introduces a new array of design criteria,
encompassing parameters such as viscosity, viscoelasticity, cell
supportive ability and gelation kinetics, which require further
characterisation (Figure 1) (Ersumo et al., 2016; Kyle et al., 2017).
Ideally, the bioink should possess the biomechanical properties
to allow easy extrusion at low shear forces during printing,
whilst supporting cell growth and maintaining shape fidelity
post-printing (Jessop et al., 2017). Other considerations include
biocompatibility with the chosen cell type, allowing not only cell
survival but promotion of cellular proliferation, differentiation
and extracellular matrix secretion to promote formation of the
target tissue (Kyle et al., 2017). Taken together these features
can be defined as the “bio-printability” properties of bioinks.
Such customisable technology means that properties required of
candidate bioinks may not be equally weighted; resolution may
be more important for one type of application and cell supportive
ability might be more sought after for another (Malda et al.,
2013). In addition, biological variation in the behaviour of even
identical cell lines means that outcomes can differ independently
of the bioink, adding to the complexity of research in this field
(Hutmacher, 2000; Ersumo et al., 2016).
Advanced bioinks are now being designed to significantly
improve printability and biocompatibility (Kyle et al., 2017).
These can be achieved through careful control of various
physical, chemical and biological properties. Biomechanical
properties that can be assessed include rheology (viscosity,
shear-thinning, viscoelasticity, and thixotropy), gelation kinetics,
crosslinking and network architecture (Murphy et al., 2013;
Jia et al., 2014; Blaeser et al., 2016). Biocompatibility can
also be altered through biofunctionalisation which can affect
cell function (cytocompatibility, cell adhesion, migration,
proliferation, and differentiation) as well as biodegradation of
materials (Skardal et al., 2012; Levato et al., 2014; Muller et al.,
2015; Daly et al., 2016). The tunability of these scaffolds also
serve the purpose of helping protecting cells (from stresses) and
allowing them to achieve the highest degree of viability (Sharma
et al., 2020).
The aim of this systematic review was to identify the types
of bioinks that have been used to date for extrusion-based
3D bioprinting and analyse their biomechanical characteristics,
biocompatibility and bioprinting parameters so that these
may aid in decision making when selecting suitable bioinks




A systematic search for relevant articles was performed
in accordance with the recommendations of the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines (Figure 2) (Moher et al., 2015) to evaluate
the types of biomaterials that have been used as bioinks for
extrusion 3D bioprinting. Preclinical studies were identified
through a systematic search across electronic databases Web of
Science (Web of Science Core Collection, BIOSIS Citation index,
KCI-Korean Journal Database, MEDLINE, SciELO Citation
Index), PubMed, Scopus, OVID and Embase, from December
2006 to November 2017. Search terms included: “3d print”
OR “3-dimensional print” OR “bioprint” OR “print” OR
“additive manufacturing” OR “extrusion” OR “extrusion-based”
OR “deposition” OR “pneumatic” OR “piston” OR “screw” AND
(“bioink” OR “cell” OR “ink” OR “scaffold” OR “hydrogel”).
Eligibility Criteria
The eligibility for including articles in this systematic review were
as follows: (1) all studies included involved extrusion bioprinting;
(2) either using animal or human cells; (3) both in vitro and
in vivo studies; (4) English language articles only.
Exclusion Criteria
Studies were excluded if they met the following criteria: (1)
no bioprinting component; (2) involved non-extrusion based
bioprinting techniques; (3) contained no biomaterial component;
(4) contained no cellular component; (5) were not available for
viewing. Review articles and commentaries were also excluded.
Study Selection
Two reviewers (S.P.T. and Z.M.J.) independently reviewed the
studies with differences resolved by the senior author (I.S.W.).
The bibliographies of relevant articles were studied to identify
further relevant publications (Figure 3). Titles were initially
screened to exclude duplicates and further screened using the
abstracts against inclusion and exclusion criteria. Finally, full text
review of the remainder was performed to assess of eligibility.
Data Extraction and Main Outcomes
Data was extracted from the selected studies using a standardised
format (Microsoft Office Excel 2016). The initial tabulated
data collection included; bioink composition, biomechanics
(compressive, elastic and shear storage moduli, viscosity or as
stated in Supplementary Table 1 as MCS/CM/EM/RCS/SM),
crosslinking type, bioprinter type, type of extrusion technique
(pneumatic, mechanical, piston, screw), printing parameters
(resolution, speed), cell source, cell viability and target tissue.
Also noted were study authors, study design (in vitro/in vivo) and
year of publication.
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FIGURE 1 | 3D printer parameters, bioink properties, and cell characteristics for optimum bio-printability (Chang et al., 2008; Derby, 2012; Zhang and Cui, 2012;
Kirchmajer et al., 2015).
RESULTS
Types of Bioinks Used for Extrusion
Bioprinting
A total of 9,720 studies were identified, 123 of which met
inclusion criteria, consisting of a total of 58 reports using natural
biomaterials, 26 using synthetic biomaterials and 39 using a
combination of biomaterials as bioinks. Alginate (n = 53) and
PCL (n = 30) are the most common types of bioink, followed
by gelatin (n = 18) and methacrylated gelatin (GelMA) (n = 16)
(Figure 3).
Improvements in technology and biomaterial availability
have resulted in an upward trend in the number of studies
using bioinks for extrusion. There is a marked increase
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FIGURE 2 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart of included studies.
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FIGURE 3 | The individual distribution frequency of natural (A) and synthetic (B) bioinks used in the analysed literature.
FIGURE 4 | Bioink type frequency in relation to the year of study.
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FIGURE 5 | Bioprinting resolution for natural-derived bioinks.
in the use of all three bioink types (natural, synthetic,
and blend) published between 2013 and 2014 and to a
lesser degree between 2015 and 2016 (Figure 4). There has
been a disproportional increase in the amount of natural
bioinks used in the literature compared to synthetic and
blend bioinks suggesting increasing popularity in biomimetic
approaches (Figure 4).
Pneumatic extrusion bioprinting techniques were the most
common (n= 78), followed by piston (n= 28). Most studies have
focused on bone and cartilage as the target tissue type, although
bioprinting of solid organs e.g., liver/heart is gaining traction
(Supplementary Table 1).
Most natural bioinks printed within 1.0mm resolution.
Alginate and HAMA were found to demonstrate the greatest
range of printing resolution possible with natural bioinks (0.1–
2.4mm), followed closely by gelatin and collagen (Figure 5).
Most synthetic bioinks printed within 0.5mm resolution except
for PCL, pHMGCL and PGLA which demonstrated the greatest
range (0.1–1.7mm) (Figure 6). The lowest resolution printed
over all the bioinks (natural, synthetic, or blends) was with a
synthetic material; HPMAm-lac-PEM at 0.025 mm.
From the 123 papers that were analysed, 36 (29%) were in-
house printers and 87 (71%) were commercial variations. The
analysis of the printing speed and resolution in relation to
the bioprinter model used showed a broad scope and range
(Figures 7, 8). This is likely to reflect differences in researcher
preferences and technical limitations of the different printers
used: even the same bioprinter model has varying ranges in
both speed and resolution. The 3D Discovery displayed the
greatest range of bioprinter speed and resolution of all the
models included in this review. However, this is also affected
by the tissue type being printed; some cells can only be able to
withstand certain printing resolutions and speeds. The lowest
printed resolution was the Bioscaffolder at 0.025mm and the
quickest speed at 60 mm/s with the Printrbot (Printrbot, USA).
It was not possible to directly compare biomechanical
properties of bioinks used in the literature due to the
heterogeneity of mechanical tests used and timing of testing (i.e.,
pre or post printing, pre or post crosslinking, pre or post tissue
maturation). Instead, the most commonmechanical moduli used
in studies for each tissue type was determined to provide an
indication of the most useful biomechanical tests. The results
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FIGURE 6 | Bioprinting resolution for synthetic-derived bioinks.
show that compressive modulus was the most frequently applied
modulus overall and the most used for bone and cartilage tissues
(Figure 9). Elastic modulus was more commonly applied than
compressive modulus for a range of soft tissue, including muscle
and vascular tissues. Hard tissues within the literature mostly
referred to bone and bone derived tissue types (Nikolova and
Chavali, 2019). Residual and maximum compressive stress were
used least frequently.
DISCUSSION
Within the last 5 years, development of bioinks have mirrored
the exponential growth of research in the 3D bioprinting field.
The justification for this growth appears to be 2-fold: firstly the
previous two decades have witnessed significant developments
in printing technology and stereolithography, secondly, as this
systematic review has illustrated, the efforts to engineer and
combine novel bioinks have yielded a plethora of printable
biomaterials for tissue engineering purposes (Tarassoli et al.,
2018b). In line with the expansion of literature in the field of
bioink materials and their combination in blends, there has been
a call for comprehensive summaries in the field to facilitate the
informed design, characterisation and development of further
novel bioinks (Ersumo et al., 2016). This systematic review is
the first to comprehensively identify the range of biomaterials
suitable for extrusion 3D bioprinting, correlate approaches to the
different target tissues and evaluate the scope of themethods used
to quantify their mechanical properties.
There has been a clear shift towards the use of natural
over synthetic scaffolds which may mirror the refinement
of natural bioink extraction technology, increased availability
and decreased cost. It suggests that research in the field is
prioritising biomimicry over customisability. Although synthetic
biomaterials were generally found to provide higher printing
resolution and allowed tuning of rheological properties through
blending (Gopinathan and Noh, 2018), natural bioinks have
greater biocompatibility and biodegradability characteristics.
Bioinks containing blended biomaterials provide the ability to
augment the biological andmechanical properties of onematerial
with another. However, our systematic review has demonstrated
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FIGURE 7 | Bioprinting speed for different models of commercial bioprinters.
that the percentage of published literature using pure bioinks (i.e.,
not blended or modified beyond the initial extraction/production
stage) has more than tripled between 2012 and 2018 which could
be attributed to the discovery of novel natural biomaterials with
shear thinning properties to allow extrusion as well as improved
extraction, chemical modification and crosslinking techniques,
enabling individual properties to be maximised. Alginate was
the most widely used natural material (n = 50), followed by
gelatin (n = 18) and methacrylated gelatin (GelMA) (n = 16),
whilst PCL was the most commonly used synthetic material
(n = 33) for bioink composition. The rationale for alginate
use was generally not specified in the included studies, though
many did acknowledge that alginate was “the most abundant
biomaterial in current bioprinting techniques” (Hill et al., 2006;
Lee et al., 2013). Alginate has been widely used in the literature,
as a matrix designed for cell encapsulation, due to its versatile,
facile, and rapid crosslinking and ability to be mass-produced
on a large scale at low cost (Purcell et al., 2009). Fifty litres
of 2% alginate solution can be produced from 1 kg alginate,
costing <£100 to purchase (SigmaAldrich, 2021a). Compared
to alternative natural bioinks such as hyaluronic acid (£57 per
gramme) (SigmaAldrich, 2021b). Chemical crosslinking enables
gelation within seconds providing an ideal environment for
cell storage, proliferation, and differentiation (Galateanu et al.,
2012). PCL, on the other hand, has been used predominantly
as a mechanically supportive bioink and can be blended with
a matrix bioink to provide encapsulation as well as superior
mechanical stability (Lee et al., 2013). This may explain why
PCL was identified as a widely used bioink for cartilage and
bone tissue engineering (Steffens et al., 2016; Stichler et al.,
2017). Support bioinks tend to be synthetic polymers, like
PCL, due to their thermosensitivity (and thus blendable) which
provides controlled biodegradation/bioprintability (Kundu et al.,
2015). This thermosensitivity can be taken advantage of by
a modification of extrusion printing called “melt blending
technology”; polymers that have good mechanical properties
with moderate melt viscosity can be blended with other similar
polymers in heated extruders (Jiao et al., 2019). PCL has also
been found to be effective in both neural (Lee et al., 2017) and
hepatic (Lee et al., 2016) tissue engineering, which require vastly
different cell culture and bioprinting techniques. This versatility
also justifies its popularity as a bioink in the literature. PCL
bioprinting can also be combined with other techniques such as
electrospinning (Lee et al., 2017) further illustrating its versatility
in the field of bioengineering.
Our systematic review revealed that one of the major
limitations of most extrusion bioprinting studies is opting for one
or two specific bioinks with the goal of engineering a specific
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FIGURE 8 | Bioprinting resolution for different models of commercial bioprinters.
tissue type rather than side by side comparisons of bioinks to
assess their overall properties and suitability. Akkineni’s group
(Akkineni A. et al., 2016; Akkineni A. R. et al., 2016) used
alginate in 4 separate studies solely for engineering cartilage
tissue. For the purposes of their studies, their specific aim was
achieved, but it provides limited information on printability and
biocompatibility of alginate bioinks overall. Similarly, Dubbin
et al. (2017) and Fedorovich et al. (2008, 2009, 2011a,b) assessed
synthetic-natural blends (PEGDA and Lutrol F127, respectively)
for bone bioprinting using only certain cell types as well thus
limiting the potential for full appraisal of those biomaterials.
Mesenchymal stem cells appeared to be most commonly used
cell source: a product of the dominance of bone and cartilage
tissue engineering studies and the relative ease of obtaining
mesenchymal stem cells over alternative stem cell sources.
The availability and cost effectiveness of bioprinters has
improved significantly in the past few years (Tarassoli et al.,
2018a) reflected in the range of bioprinters used in the
studies we analysed (Figures 7, 8). There is no “gold standard”
bioprinter or extrusion technique and the increasing versatility
and customisability of the printers provides a wider capacity
for research. Pneumatic force was the most commonly used
extrusion technique in those studies that identified the mode
of extrusion (64% or 78 out of 123 studies) and suitable for
both natural, synthetic and blend bioinks (Liu et al., 2017),
followed by piston force technique (n = 28). The Bioscaffolder
(GeSiM, Germany), 3D Discovery (regenHU, Switzerland) and
Bioplotter (EnvisionTEC, Germany) were the most commonly
used commercial bioprinters (n = 35), but interestingly groups
most often opted to create their own in-house devices (n = 20).
This is most likely due to the low cost of producing such a printer
(much of the software and firmware used is open-source; Reid
et al., 2016) and the associated potential limitless customisability.
The printing speeds ranged from between 2 and 60 mm/s and
printing resolutions ranged from 0.025–2.4mm in the studies
that had a full complement of printing information, with no
discernible differences between commercial or in-house devices.
We found huge variability in the types of biomechanical tests
used to characterise bioinks (Hu et al., 2019) thereby prohibiting
direct comparisons of numerical values for moduli. Different
approaches for characterising the mechanical properties of
bioinks often reflected the target tissue type i.e., compressive tests
were more commonly used to assess biomaterials applied to bone
and cartilage tissue engineering whereas shear storage modulus
was more commonly used to assess biomaterials for engineering
soft tissues such as muscle (Figure 10). Many studies also failed
to specify whether the mechanical data reflected pre-, during or
post-printing, pre- or post-crosslinking and with or without cells
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FIGURE 9 | Frequency and class of mechanical assessment for each tissue type.
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FIGURE 10 | Flowchart highlighting the scope of tissue type produced from the studies alongside the variability of bioprinter model, bioink, and cell source.
(154) (Hegewald et al., 2009; Zadpoor, 2017). It is recognised that
biochemical makeup of a material inherently changes after cross-
linking, incorporation of cells or secretion of extracellular matrix,
which in turn alters its biomechanical properties (Hu et al., 2019)
and this needs to be taken into account when characterising
bioinks for extrusion. The biomechanical properties required for
extrusion such as shear thinning to allow thematerial to flowwith
minimal stress to cells, are different to those post-crosslinking or
following a period of cellular differentiation andmatrix secretion,
which should mirror mechanical properties of target tissue type
(10, 15).
Emerging Future Trends From Recent
Literature
A further search was carried out to include the literature from
2019 to 2021 using the PRISMA guidelines (Moher et al.,
2015) and the same inclusion and exclusion criteria to allow
us to establish the emerging recent trends in extrusion 3D
bioprinting literature and compare and contrast this to our
findings from the previous 12 years (2006–2018). A total of 104
papers met the inclusion criteria over the last 2 years, which
is 85% of the total found from the inception of the technology
to 2018. This demonstrates an exponential rise of research
in the field. The reasons for this increase are multifactorial
and likely due to the open-source nature of the technology
(i.e., the feasibility of developing an in-house printer with
easily available software), automation and customisability of
laboratory-based tissue engineering research, combined with the
increased availability of high-level work and increasing hubs of
expertise in the field.
From analysis of the recent data (2019–2021), alginate
continues to be the most widely used bioink accounting for 30%
of the literature in pure or blended form. This, however, has
reduced from 41% alginate use in literature published between
2006 and 2018 whichmay be attributed to the emergence of better
manipulated synthetic bioinks such as PCL (Diaz-Gomez et al.,
2020; Nulty et al., 2021) as well as novel natural bioinks such
as nanocellulose (Markstedt et al., 2015; Kyle et al., 2018; Jessop
et al., 2019). The most obvious trend that was found was the
increase in the tissue type aimed to be recreated. It appears that
there has been a shift from the soft tissue to hard and vascular
derived tissue. Almost 50% of the studies were recreating bone or
vessel tissue types. A hypothesis for this is the development and
discovery of various growth factors (Dreyer et al., 2021) as well
as more efficient cross-linking techniques to further the accuracy
and precision of the printed construct (Benwood et al., 2021;
Cooke and Rosenzweig, 2021; Huang et al., 2021).
The techniques of extrusion bioprinting has not changed
dramatically in the last 2 years, but there is something to be said
for more readily available commercial printers that are capable
of high printing resolution and speeds; features that were only
previously possible with industry produced equipment (Chang
et al., 2021).
CONCLUSION
This systematic review provides a snapshot of the current natural
and synthetic biomaterials that have been demonstrated to be
suitable for extrusion bioprinting different tissue types. There
is enormous breadth of bioink, bioprinter, and cell types as
well as a range in biomechanical assessments. In part, this
breadth can be attributed to the spectrum of tissue types the
bioprinting process aims to replicate as well as an indicator
that this research field is still in its infancy. There is increasing
understanding that development of bioinks needs to address both
biological properties, to support cell survival, proliferation, and
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differentiation, as well as biomechanical properties, to enable
dispersion initially as a printed gel, and thereafter as a robust and
durable solid tissue. Future research will need more transparency
on the biomechanical properties required for different stages
of the bioprinting process (pre-printing, shear thinning, post-
crosslinking, and post-ECM formation) as well as head-to-head
comparisons of different bioinks. The biomechanical suitability
of the bioprinted tissue end-products will need to be assessed in
the context of native tissue biomechanics and clinical end use
application. Appropriate biomechanical methods that best assess
in vivo stress requirements will need to be established to allow
direct comparisons of bioink types. In addition, considering that
the inclusion criteria for this systematic review meant that only
studies involving cells in combination with biomaterials were
included, it was surprising to find that more half of the studies
analysed did not assess cell viability explicitly not to mention
effects of proliferation or differentiation of bioinks on different
cell types. There have been incremental developments in the field
over the past 10 years, and the further refinement of bioprinting
processes and bioink optimisation holds exciting potential for
revolutionising tissue engineering approaches. It is difficult to
speculate on what the landscape will be in several years of a
decade, but the current frame within the literature is trending
towards accuracy as well as precision (Bisht et al., 2021). The field
of bioprinting will not be a “on size fits all” approach and unlikely
to become a large-scale production of the technology, but rather
a bespoke technology that will be produced depending on the
patient’s needs as well as the clinical application (Alcala-Orozco
et al., 2021; Ji and Guvendiren, 2021).
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